Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$8.49
-0.31-3.52%
At close: -
$8.40
-0.09-1.06%
After Hours: 9:13 AM EDT
Comments
Loading...
Pharming (NASDAQ:PHAR) Stock, Analyst Ratings, Price Targets, Forecasts
Pharming Group has a consensus price target of $27 based on the ratings of 3 analysts. The high is $37 issued by HC Wainwright & Co. on December 17, 2024. The low is $14 issued by Jefferies on December 9, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on December 17, 2024, December 16, 2024, and December 11, 2024, respectively. With an average price target of $37 between HC Wainwright & Co., there's an implied 340.48% upside for Pharming Group from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Jefferies
Oppenheimer
1calculated from analyst ratings
Analyst Ratings for Pharming
Data brought to you by Benzinga APIs
FAQ
What is the target price for Pharming (PHAR) stock?
The latest price target for Pharming (NASDAQ:PHAR) was reported by HC Wainwright & Co. on December 17, 2024. The analyst firm set a price target for $37.00 expecting PHAR to rise to within 12 months (a possible 340.48% upside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Pharming (PHAR)?
The latest analyst rating for Pharming (NASDAQ:PHAR) was provided by HC Wainwright & Co., and Pharming reiterated their buy rating.
When was the last upgrade for Pharming (PHAR)?
There is no last upgrade for Pharming
When was the last downgrade for Pharming (PHAR)?
There is no last downgrade for Pharming.
When is the next analyst rating going to be posted or updated for Pharming (PHAR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pharming, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pharming was filed on December 17, 2024 so you should expect the next rating to be made available sometime around December 17, 2025.
Is the Analyst Rating Pharming (PHAR) correct?
While ratings are subjective and will change, the latest Pharming (PHAR) rating was a reiterated with a price target of $37.00 to $37.00. The current price Pharming (PHAR) is trading at is $8.40, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.